LAUREN DEMARCO: Open Payments
NPI 1992164602 · BOONTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,655 in 164 payments from 26 companies in 2025. Trend: 2023 $2,197 · 2024 $2,512 · 2025 $2,655
Food & beverage: $2,655
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $491 |
| Novo Nordisk Inc | 19 | $335 |
| Axsome Therapeutics, Inc. | 16 | $273 |
| Amgen Inc. | 14 | $210 |
| PFIZER INC. | 13 | $174 |
| Lilly USA, LLC | 8 | $129 |
| Neos Therapeutics, LP | 7 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $125 |
| Exact Sciences Corporation | 4 | $85 |
| Kowa Pharmaceuticals America, Inc. | 5 | $80 |
Products named: UBRELVY, Auvelity, Wegovy, OTEZLA, Adzenys XR-ODT, CAPLYTA, MOUNJARO, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
